Tech Company Financing Transactions

Angstrom Pharmaceuticals Funding Round

Tech Coast Angels participated in a $20 thousand capital raise for Angstrom Pharmaceuticals. The round was announced on 9/30/2013.

Transaction Overview

Announced On
9/30/2013
Transaction Type
Venture Equity
Amount
$20,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10655 Roselle St. 314
Solana Beach, CA 92121
USA
Email Address
Overview
Angstrom is conducting a Phase 2 clinical trial for the treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).
Profile
Angstrom Pharmaceuticals LinkedIn Company Profile
Social Media
Angstrom Pharmaceuticals Company Twitter Account
Company News
Angstrom Pharmaceuticals News
Facebook
Angstrom Pharmaceuticals on Facebook
YouTube
Angstrom Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Malcolm Finlayson
  Malcolm Finlayson LinkedIn Profile  Malcolm Finlayson Twitter Account  Malcolm Finlayson News  Malcolm Finlayson on Facebook
Chief Financial Officer
Dale Kostman
  Dale Kostman LinkedIn Profile  Dale Kostman Twitter Account  Dale Kostman News  Dale Kostman on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2013: BodyShopBids venture capital transaction
Next: 9/30/2013: nWay venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary